Since NAT2 single-nucleotide polymorphisms (SNPs) are responsible for the efficacy of arylamines and hydrazine drugs, defining the effects of these SNPs in various ethnicities is an important factor in the development of personalized medicine. In the present study, we examined the expression efficiency of NAT2 using promoter haplotypes identified in a Korean population. To construct NAT2 promoter haplotypes, seven NAT2 promoter SNPs (rs4646241, rs4646242, rs4646243, rs4646267, rs4345600, rs4271002 and rs4646246) were genotyped in a total of 192 Korean subjects. A luciferase assay was performed using the three commonest haplotypes to evaluate enzyme expression level of NAT2 promoter haplotypes. The most common haplotype (TACGAGG) showed the lowest enzyme expression level (0.72 ± 0.06 relative light units (RLU)/[β-galactosidase]). The second (CGTAAGA) and third (TATAACA) commonest haplotypes showed intermediate and the highest enzyme expression level (0.99 ± 0.05 and 1.45 ± 0.11 RLU/[β-galactosidase]), respectively. Haplotype comparison among populations showed that Asian populations had a high proportion of the haplotype for lowest enzyme expression. Haplotype frequencies of Caucasian and African ethnicities were markedly different from those of Korean ethnicity. Results from the present study should contribute to the expansion of our current understanding of the pharmacogenetics field.
INTRODUCTION
Because genetic differences among individuals and populations cause variability in drug responses, defining the genetic background of pharmacogenes is an important factor to achieve personalized medicine. Drug metabolism can be divided into phase I and phase II metabolism. Phase I metabolism converts a drug into more water-soluble metabolites by oxidation, reduction and hydrolysis, while phase II metabolism makes a drug into a more water-soluble and inactive form by conjugation of subgroups such as -OH and -SH. Since these two types of metabolism are important for drug efficiency, recent pharmacogenetic studies have concentrated on phase I and phase II genes such as the N-acetyltransferase (NAT) family, the Cytochrome P450 (CYP) family and the Uridine diphosphate glucuronosyl transferase (UGT) family (Court et al., 2013; Iwano et al., 2014; Sim et al., 2014) . N-acetyltransferase 2 (NAT2) is a well-known phase II enzyme which is mainly expressed in liver, small intestine and colon (Ruiz et al., 2009) . The functional role of the enzyme is transmission of an acetate group to the nitrogen or oxygen of aromatic amines. The enzyme uses hydrazines and N-hydroxylamines as substrates. This enzyme activity mediates both activation and deactivation of arylamines, hydrazine drugs and carcinogens (Vatsis et al., 1995; Windmill et al., 1997) . According to previous studies, human populations can be divided into rapid, intermediate and slow acetylators based on their drug detoxification rate. Moreover, it has been demonstrated that NAT2 polymorphisms are responsible for the acetylation efficiency (Vatsis et al., 1991) . Therefore, polymorphisms in NAT2 are regarded as important markers for prediction of drug detoxification capability in individuals.
Numerous studies have been conducted to determine the impact of NAT2 polymorphisms on acetylator phenotypes (Hein and Doll, 2012; Suarez-Kurtz et al., 2012; Eny et al., 2014) . Consequently, it was reported that several nonsynonymous SNPs (nsSNPs), such as rs1805158 (R64W), rs1801279 (R64Q), rs1801280 (I114T) and rs1799931 (G286E), are observed in slow acetylators. It was also demonstrated that rs1041983 (Y94Y) and rs1208 (R268K) were present in rapid acetylators. The frequency of the polymorphisms showed different distributions based on ethnicities. In addition, it was reported that NAT2 promoter polymorphisms also contribute to alteration of acetylation phenotype. However, most previous studies focused on nsSNPs, even though promoter polymorphisms can change the gene expression level by changing transcription factor binding affinity or the proportion of alternative splicing (Pagani et al., 2002; Yuan et al., 2005) .
In the present study, we examined the effect of NAT2 haplotypes on gene expression. We also compared allele frequencies and haplotypes in five different ethnicities.
MATERIALS AND METHODS
Study subjects A total of 192 DNA samples of a Korean population, which were provided by Sungkyunkwan University Hospital, were used for initial sequencing and haplotype identification. The institutional review board (IRB) of Sungkyunkwan University Hospital approved the study protocol, and all subjects provided informed consent (IRB approval number: SKKUP-2009-003).
Genotyping and haplotype analysis The promoter region of NAT2 was polymerase chain reaction (PCR)amplified and genotyped using an ABI PRISM 3730 genetic analyzer (Applied Biosystems, CA, USA). Prim-ers for the amplification and sequencing analysis were designed using Primer3 software (http://frodo.wi.mit.edu) based on the sequence of NAT2 available online (reference genome sequence: NG_012246.1) (Rozen and Skaletsky, 2000) . The primers used for amplification are listed in Supplementary Fig. S1 . Sequence variants were verified by chromatograms using SeqMan software. As a result of the genotyping, a total of seven NAT2 promoter SNPs were detected and used to construct haplotypes. With the seven SNPs, we estimated haplotypes and their frequencies using PHASE software (Stephens et al., 2001) . Additional in silico analysis was performed using TFsearch (http://www.cbrc.jp/research/db/TFSEARCH.html) to predict potential effects of polymorphisms on transcription factor binding affinity.
Functional characterization of NAT2 promoter haplotypes by luciferase assay For each haplotype, a unique primer set was designed using Primer3; primer sequences are displayed in Supplementary Table  S1 . After PCR, the terminal restriction sites of amplified DNAs were cut by SacI and XhoI and ligated into the multiple cloning region of pGL3 vector (Promega, CA, USA). We directly sequenced the clones to analyze allele sequences and confirm the reference sequence. Based on the reference sequence, point mutagenesis was conducted to produce clones of different haplotypes. Lipofectamine 2000 (Invitrogen, CA, USA) was used to transfect HepG2 cells with the mutagenized DNAs. After transfection and cell lysis, a Luciferase Assay kit (Promega) was used to conduct the luciferase assay reaction according to the manufacturer's guide. A luminometer (VICTOR 3 Multilabel counter, 1420, Perkin Elmer, MA, USA) was used to measure luciferase activity. To correct for efficiency differences caused by each promoter's different luciferase expression activity amount, we conducted a β-galactosidase assay using a β-galactosidase Assay kit (Promega, #E1081) according to the manufacturer's guide. A fixed amount of β-galactosidase control vector To compare haplotype differences among ethnicities, we obtained genotypes for other populations from the 1000 Genomes database (http://browser.1000genomes. org/). Detailed frequencies of SNPs and haplotypes are shown in Table 1 and Table 2 , respectively. According to the result, the most common haplotype of Asian populations had the same allele composition (TACGAGG) and 
-" hyphen indicates that the haplotype has not been found in the corresponding ethnicity. was co-transfected with various concentrations of vector for luciferase expression. Consequently, an increased expression level of luciferase was observed in a concentration-dependent manner. We used a t-test to examine the difference in luciferase activity for each haplotype (P < 0.05 for significant difference).
RESULTS
To evaluate the impact of the NAT2 promoter haplotypes on enzyme expression level, we used seven polymorphisms (rs4646241, rs4646242, rs4646243, rs4646267, rs4345600, rs4271002 and rs4646246) which showed a frequency over 0.05 to construct haplotypes. Genotyping was performed on samples from a total of 192 Korean subjects, which were provided by Sungkyunkwan University Hospital. The samples comprised healthy women aged from 33 to 78; the average age was 56.1 ± 7.4. Detailed frequencies of each allele are displayed in Table 1 . We then inferred haplotypes and used the three haplotypes which showed a frequency of over 10% in these Korean samples for further functional analysis (Table 2) .
A luciferase assay was performed to compare the expression efficiency among NAT2 promoter haplotypes. The enzyme expression levels are presented as relative light units (RLU), which were obtained by dividing luciferase RLU by β-galactosidase concentration (Fig. 1) . KR_Hap 3 (TATAACA) showed the highest expression level among all haplotypes (1.45 ± 0.11 RLU/[β-galactosidase]), while showed similar proportions (47.6% in Korean, 55.7% in Japanese and 48.9% in Chinese). Also, haplotype frequencies for Caucasian and African populations were distinctly different from those of the Korean population.
Additional in silico analyses were conducted for the seven SNPs to predict their possible functional role. TFsearch (http://www.cbrc.jp/research/db/TFSEARCH.html) was used to investigate the effect of polymorphisms on expression efficiency. Among the seven SNPs, only one polymorphism, rs4646241, was estimated to occur in a regulator of a transcription factor binding site for the POU domain transcription factor TST-1, with a score of 91.7. These analyses predicted that the other SNPs are not associated with transcription factor binding affinity.
DISCUSSION
It has been demonstrated that polymorphisms in NAT2 exon regions affect slow acetylation phenotypes by changing substrate affinity, changing catalytic activity, and/or decreasing the stability of NAT2 protein; however, functional effects of SNPs in the NAT2 promoter region have not yet been reported. In the present study, we estimated common promoter haplotypes in a Korean population and calculated the frequency of these haplotypes. The most common promoter haplotype of Korean, KR_Hap 1, had a frequency of 47.6% and showed the lowest enzyme expression level among the top three haplotypes used in thre present study. The second and third commonest haplotypes, KR_Hap 2 and KR_Hap 3, were responsible for moderate and high levels of NAT2 expression.
To compare ethnic differences, we obtained genotypes of four populations from the 1000 Genomes database and constructed haplotypes using PHASE software. The most common haplotype of Japanese and Chinese populations was the same as that of the Korean population, ~50% in all three populations. Also, the most frequent haplotype in Caucasian and African populations (TATAAGA; 38.8% and 33.5%, respectively) showed low frequency in all Asian populations ( < 6%). Only the second haplotype of African and Caucasian populations was included in the top three haplotypes of the Korean population. In addition, the second top haplotype of the African population (TATAAGG; 26.7%) was not observed in any of the other populations. Comparison of the NAT2 expression efficiency of frequent promoter haplotypes among ethnicities may be helpful for further understanding of these population differences and of the association of expression efficiency to acetylation phenotype.
In the present study, we report that the most common NAT2 haplotype in the Korean population (TACGAGG; frequency = 47.6%) is associated with a low expression level of NAT2. Our result seemed inconsistent with previous studies which reported a low frequency of the slow acetylation phenotype in Asian populations (Butcher et al., 2002; Lee et al., 2002; Kang et al., 2009 ). However, NAT2 was not the only factor used for determination of the acetylation phenotypes; other acetylation-associated enzymes were included, such as NAT isozymes, as well as NAT1. In addition, genetic differences in acetylation-related genes among Asian populations can also influence the frequency of slow and fast acetylators. In the case of NAT2, a previous study using a Korean population reported that some polymorphisms showed different frequencies compared to those in other Asian populations including Chinese and Japanese (Kang et al., 2009 ). These results imply that comprehensive considerations, including other acetylation enzymes and genetic factors, must be taken into account for precise prediction of acetylation phenotypes.
To predict the possible role of these polymorphisms, we performed in silico analyses using TFsearch to investigate the impact of polymorphisms on transcription factor binding affinity. The prediction tool showed that the allele change in rs4646241 (TTAATCATT to TTAATTATT) might result in a new transcription factor binding site for the POU domain transcription factor TST-1. According to previous reports, TST-1 is a trans-activator which mediates 5′-TTAATCATT-3′ motif-dependent transcription. It has also been demonstrated that TST-1 acts as a transcriptional regulator in pancreatic β-cells (Baumeister and Meyerhof, 2000) . However, we failed to find a significant relationship between rs4646241 and enzyme expression level. Further molecular studies will be needed to investigate the exact role of rs4646241 in regulating NAT2 expression level.
In conclusion, we examined the impact of NAT2 promoter haplotypes on enzyme expression in a Korean population. As a result, the most common haplotype in the Korean population showed the lowest enzyme expression level. Also, the second and third commonest haplotypes showed intermediate and the highest expression level, respectively. The result of a comparison of haplotype frequencies with other populations revealed that haplotypes of other Asian populations were similar to those of the Korean population. Haplotypes of Caucasian and African populations were markedly different from those of the Korean population. The present study should contribute to the expansion of current phamacogenetic knowledge.
